🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.

Some experts said the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed problematic material and banned related keywords and search suggestions. The organization stated it was committed to maintaining the service safe and investing in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found groups with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with numerous of members, filled with images of weight loss, glowing reviews and step-by-step guides for preparing or injecting at home.

After moments of entering one community, a seller shared WhatsApp details, where most purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Item Details and Pricing

Inside these communities, posts show black plastic packages with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered patients injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to possibly serious health risks”.